- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03293212
Characteristics and Medical Resource Utilization of Postoperative Patients
Characteristics and Medical Resource Utilization of Postoperative Patients: A Cross-sectional Survey of Outpatients
Visão geral do estudo
Status
Condições
Descrição detalhada
A considerable number of patients suffer prolonged chronic pain that does not retract or diminish after surgery, and are thus unable to achieve the desired results in receiving surgical treatment. Postoperative pain is gradually being perceived as a social issue as opposed to a personal health condition. Meanwhile, although efforts to address chronic pain with integrative medicine are continued in answer to the lack of success of pain management through surgery, there is still a lack of supporting evidence.
The objective of this survey study is to assess the characteristics, usage of conventional and Korean medical services, and prognosis by period before and after surgery in postoperative patients visiting a Korean medicine hospital, and analyze the associations between the preference for conventional and Korean medicine treatment. This study therefore investigates the usage of conventional and Korean medical services in postoperative patients, and is expected to provide information that will potentially aid patient decision making.
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
-
Seoul, Republica da Coréia
- Jaseng Medical Foundation
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Patients with chief complaint(s) of at least one or more of the following: low back pain (or radiating leg pain), neck pain (or radiating arm pain), knee pain, or shoulder pain
- Patients with a history of musculoskeletal surgery related to the chief complaint(s)
- Patients capable of effective communication with the researcher(s) and understanding the survey items
- Patients who have given written informed consent
Exclusion Criteria:
- Patients without a history of musculoskeletal surgery associated with the low back, neck, shoulder, or knee region(s)
- Patients whose current pain is mainly attributed to traffic accident injury
- Patients incapable of answering the researcher interviews and surveys
- Patients with other reasons rendering study participation inappropriate as judged by the researcher(s)
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Numeric rating scale (NRS) of pain
Prazo: Within 7 days after 1st visit
|
11-point pain scale
|
Within 7 days after 1st visit
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Five level version of EuroQol-5 Dimension (EQ-5D-5L)
Prazo: Within 7 days after 1st visit
|
Health-related quality of life questionnaire consisting of 5 descriptive items and EQ Visual Analogue Scales (EQ-VASs)
|
Within 7 days after 1st visit
|
|
Functional disability questionnaire (for low back pain patients as indicated by postoperative condition)
Prazo: Within 7 days after 1st visit
|
Oswestry Disability Index (ODI)
|
Within 7 days after 1st visit
|
|
Functional disability questionnaire (for neck pain patients as indicated by postoperative condition)
Prazo: Within 7 days after 1st visit
|
Neck Disability Index (NDI)
|
Within 7 days after 1st visit
|
|
Functional disability questionnaire (for knee pain patients as indicated by postoperative condition)
Prazo: Within 7 days after 1st visit
|
Western Ontario McMaster Universities Osteoarthritis Index (WOMAC)
|
Within 7 days after 1st visit
|
|
Functional disability questionnaire (for shoulder pain patients as indicated by postoperative condition)
Prazo: Within 7 days after 1st visit
|
Shoulder Pain and Disability Index (SPADI)
|
Within 7 days after 1st visit
|
|
Work Productivity and Activity Impairment Questionnaire: General Health (WPAI-GH)
Prazo: Within 7 days after 1st visit
|
Questionnaire assessing the effect of health problems on the ability to work and to perform regular activities
|
Within 7 days after 1st visit
|
|
Beck Depression Inventory-II (BDI-II)
Prazo: Within 7 days after 1st visit
|
The Korean version of the BDI-II has been validated and consists of 21 multiple choice items for diagnosis of depression.
|
Within 7 days after 1st visit
|
|
Medical service use
Prazo: Within 7 days after 1st visit
|
Type(s) of medical service use before and after surgery post-onset
|
Within 7 days after 1st visit
|
|
Medical costs
Prazo: Within 7 days after 1st visit
|
Medical costs from medical service use before and after surgery post-onset
|
Within 7 days after 1st visit
|
|
Satisfaction with and preference for conventional and Korean medicine
Prazo: Within 7 days after 1st visit
|
Satisfaction with and preference for conventional and Korean medicine as measured using a 9-point Likert scale
|
Within 7 days after 1st visit
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: In-Hyuk Ha, KMD, M.Sc., Jaseng Medical Foundation
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- JS-CT-2017-03
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .